Corvus Pharmaceuticals, Inc.'s See Remarks just declared owning 113,773 shares of Corvus Pharmaceuticals, Inc.

William Benton Jones, Corvus Pharmaceuticals, Inc.'s See Remarks, has just filed an initial statement of beneficial ownership where 113,773 shares of Corvus Pharmaceuticals, Inc. were declared. This form is usually filed as a prelude to receiving options or buying company shares, so there may be more to come from Jones. Jones operates out of Burlingame, CA. Some additional info was provided as follows:


A portion of these shares is subject to a right of repurchase held by the Issuer.
The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with th e Issuer on each such vesting date.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh

Feedback